GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...
With foodborne illnesses and changes in Medicare and Medicaid coverage, University of Virginia (UVA) Health experts say never ...
Phoenix NP announced a continued rise in patient satisfaction across Arizona, noting that positive feedback has increased as more women seek safe, FDA-approved GLP-1 weight loss medications through ...
Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a ...
Private health insurance premiums will be going up in 2026 — in some cases, by a lot. Congressional Democrats and Republicans ...
Eli Lilly's experimental drug, retatrutide, showed strong results in a late-stage trial, helping patients lose nearly 29% of ...
They're leading to reduced grocery spending, healthier food choices, wardrobe changes, and altered dining habits. The drugs ...
Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback